An article recently published in Molecular Psychiatry 1 reported that the cadherin gene (FAT) was associated with increased occurrence of bipolar affective disorder (BPAD) in four independent cohorts. The present investigation attempted to replicate these findings in a different cohort but found no significant association.
The heritable component of BPAD is unequivocal yet the identity of any risk allele remains to be consistently replicated. One proposed susceptibility locus occurs on chromosome 4q35. [2] [3] [4] Blair et al.
1
undertook positional cloning, association tests and gene expression assays and found support for a role of the FAT gene, that resides within that chromosomal region, in relation to BPAD. Our cases were recruited for a family study regarding the molecular genetics of BPAD in Christchurch, New Zealand. Probands were included in the study based on a confirmed bipolar I (BPI) or bipolar II (BPII) diagnosis, suspected family history of spectrum BPAD and at least one living first-degree family member available for interview. 5 All participants were assessed using the Diagnostic Interview for Genetics Studies (DIGS). 6 The control DNA samples were obtained from a representative local cohort for the purpose of population estimates of polymorphism frequencies. All individuals provided written informed consent. This study was approved by the Canterbury Ethics Committee, Christchurch, New Zealand.
All samples were genotyped for two of the three single nucleotide polymorphisms (SNPs) examined by Blair et al.
1 -rs1298865 and rs2306987. Genomic DNA was extracted from peripheral blood using the method of Ciulla et al. 7 Genotyping was undertaken using an allele-specific multiplex polymerase chain reaction (PCR) carried out in two reactions (A and B) for each DNA sample. Each 10 ml PCR contained 0.5 mM of each primer (Invitrogen, Carlsbad, CA, USA), 200 mM each deoxynucleoside triphosphate (Roche, Basel, Switzerland), 0.2 U of Taq polymerase (Eppendorf HotMaster, Hamburg, Germany), 1 Â PCR buffer (Eppendorf HotMaster) and approximately 100 ng of genomic DNA. Primers for reaction A included two common primers used in both reactions (5 0 -TTCTTCGTTTGAGTTTGTAAGGTG-3 0 and 5 0 -GTTAAGAAAGTTGCGAGGAAGATT-3 0 ) and two allele-specific primers for rs2306987 T and rs1298865 T, respectively (5 0 -TGCTGGGGAAAATAGCCAAACTG TTCTTCT-3 0 and 5 0 -TCGCACGATTCGGACTGGAAG GAGCTCATA-3 0 ). Primers for reaction B included the two common primers and two allele-specific primers for rs2306987 A and rs1298865 C, respectively (5 0 -TGCTGGGGAAAATAGCCAAACTGTTCTTCA-3 0 and 5 0 -TCGCACGATTCGGACTGGAAGGAGCTCATG-3 0 ). Thermal cycling was performed with an initial denaturation of 5 min at 951C, followed by 30 cycles of 30 s at 951C, 30 s at 601C, 40 s at 681C, and a terminal extension of 7 min at 681C. Reaction products were analysed on a 2% agarose (Progen Biosciences, Darra, Queensland, Australia) gel, with expected bands of 180 bp for rs2306987 alleles, 289 bp for rs1298865 alleles and 639 bp for the internal reaction control.
Our family-based sample consisted of 91 families, including 76 probands and 254 relatives for whom we had complete clinical and genetic data. Within the relatives, 109 individuals had been diagnosed with depression, 56 had some form of BPAD and 89 had no history of a mood disorder. All probands had been diagnosed with BPAD, including 57 with BPI and 19 with BPII. The mean age of the probands was 35.6 years (S.D 18.6) and 44% were male. The majority of the cohort was of Caucasian ethnicity. For the analyses, the probands were regarded as cases, while the local cohort of volunteers represented controls.
Consistent with Blair et al., 1 we performed w 2 tests to compare the allele and genotype frequencies for cases (n = 76) and controls (n = 151). For polymorphism rs1298865, there was no significant difference in allele or genotype frequencies (odds ratio (OR) = 1.33; 95% confidence intervals (CIs) = 0.76-2.34 and OR = 0.72 (95% CIs = 0.33-1.59) for the C and T alleles, respectively). Similarly, at rs2306987 allele and genotype frequencies did not significantly differ between case and control individuals (OR = 1.10 (95% CIs = 0.63-1.92) and OR = 0.46 (95% CIs = 0.20-1.08)) for the T and A alleles, respectively. However, consistent with Blair et al.
1 the rs1298865 T allele and rs2306987 A allele were more prevalent among cases (Table 1) .
Since all our cases had suspected family history of BPAD, we could not analyse this as a sub-phenotype as performed by Blair et al. 1 However, we could test for an association among cases with a history of the presence or absence of psychosis during manic or depressive episodes. Consistent with the original study, our case-control cohort showed no evidence for an association among psychosis or non-psychosis subsets.
Within our family sample, comprising parents and siblings, Family-Based Association Tests (FBAT) 8 were undertaken. An affected status equated to a diagnosis of either BPI or BPII. From 91 pedigrees, including 36 nuclear families, 15 families were informative. Using any genetic model, there was no significant evidence of transmission disequilibrium at either locus, consistent with the UK trios in Blair et al. Using the program COCAPHASE (v2.404), 9 we corroborated Blair et al.'s 1 findings of high linkage disequilibrium between the SNPs (cases: r 2 = 0.74; controls: r 2 = 0.79) and that the two common haplotypes (TA and CT) account for > 90% of the haplotype diversity in this region. However, we did not find a significant difference in haplotype frequencies between cases and controls.
In our attempts to replicate the findings of Blair et al.
1 using similar ascertainment and statistical analysis methods, we did not find support for the involvement of two FAT polymorphisms in the occurrence of BPAD. Further investigation of this proposed association is warranted within other samples to ascertain its reliability. Altered levels of trace amines have been observed in neuropsychiatric disorders such as schizophrenia and 
